Kent Imaging Recognized as Medical Imaging Technology Developers of the Year (Canada) by International Elite 100
Kent Imaging is pleased to be recognized by International Elite 100 as Medical Imaging Technology Developers of the Year (Canada) for 2024.
This award through IE100 is always an honour to receive as it recognizes leaders of innovation and quality in all areas of business, geographic regions and specializations. This is the fourth consecutive year Kent has received the accolade.
At Kent Imaging, the driving force behind the technology is to improve outcomes for as many patients as possible. SnapshotNIR, Kent’s imaging device, uses near-infrared spectroscopy (NIRS) to measure tissue oxygenation, oxyhemoglobin and deoxyhemoglobin in the microcirculatory system of each patient. This technology supports clinicians in making critical, potentially limb-saving decisions during bedside assessment and evaluation.
In Q2 of 2024, Kent Imaging announced a pivotal advancement to SnapshotNIR (KD205) with an algorithm update that optimizes NIRS imaging in almost all skin tones, effectively helping to address the melanin barrier in medical imaging and provide quality healthcare to more individuals.